140 related articles for article (PubMed ID: 35782072)
1. Analysis on the Efficacy of Bronchial Artery Chemoembolization Combined with 125I Seed Implantation in the Therapy of Advanced Non-Small-Cell Lung Cancer Based on the Medical Database.
Xie P; He L; Zhang Y
Biomed Res Int; 2022; 2022():7376844. PubMed ID: 35782072
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Evaluation of CT Imaging Big Data-Assisted Arterial Chemoembolization Combined with
Xie P; Zhang Y; He L
Comput Math Methods Med; 2022; 2022():3472982. PubMed ID: 35872936
[TBL] [Abstract][Full Text] [Related]
3. Clinical analysis of 125I seed implantation combined with epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer.
Wang X; Wang D
J BUON; 2021; 26(5):1879-1886. PubMed ID: 34761595
[TBL] [Abstract][Full Text] [Related]
4. Bronchial artery chemoembolization combined with radioactive iodine-125 seed implantation in the treatment of advanced nonsmall cell lung cancer.
Chen Y; Li Y; Jia Y; Lei K; Zhang X; Cao Y; Zhu J
J Cancer Res Ther; 2017; 13(4):636-641. PubMed ID: 28901306
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
Zhang Z; Yuan F; Chen R; Li Y; Ma J; Yan X; Wang L; Zhang F; Tao H; Guo D; Huang Z; Zhang S; Li X; Zhi X; Ge X; Hu Y; Wang J
Front Immunol; 2020; 11():1173. PubMed ID: 32587591
[No Abstract] [Full Text] [Related]
6. Efficacy of transcatheter arterial chemoembolization combined with 125I seed implantation and three-dimensional conformal radiotherapy in advanced primary hepatocellular carcinoma.
Zhang H; Yang A; Zhang J
J BUON; 2020; 25(2):952-958. PubMed ID: 32521891
[TBL] [Abstract][Full Text] [Related]
7. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Microwave Ablation Combined with Anti-PD-1 Monoclonal Antibody on T Cell Subsets and Long-Term Prognosis in Patients Suffering from Non-Small-Cell Lung Cancer.
Yu W; Sun J; Wang T; Du Y
Comput Math Methods Med; 2022; 2022():7095423. PubMed ID: 36199771
[TBL] [Abstract][Full Text] [Related]
9. [Clinical value of CEA and CYFRA21-1 as an assessment indicator of therapeutic efficacy in advanced non-small cell lung cancer patients].
Li L; Song LH; Ding SC; Zhang XJ; Qiang L; Han CY; Yuan XT; Xu DD
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):850-4. PubMed ID: 21223692
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of computed tomography-guided implantation of 125I seeds in the treatment of refractory malignant tumors accompanied with cancer pain and its influence on tumor markers in the serum.
Duan F; Su XL; Wei ZX; Kong DW; Huang TY; Wang S
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1595-1601. PubMed ID: 29630101
[TBL] [Abstract][Full Text] [Related]
11. The Role of Change Rates of CYFRA21-1 and CEA in Predicting Chemotherapy Efficacy for Non-Small-Cell Lung Cancer.
Zhao T; Mao G; Chen M
Comput Math Methods Med; 2021; 2021():1951364. PubMed ID: 34603482
[TBL] [Abstract][Full Text] [Related]
12. Combination of computed tomography-guided iodine-125 brachytherapy and bronchial arterial chemoembolization for locally advanced stage III non-small cell lung cancer after failure of concurrent chemoradiotherapy.
Chen C; Wang W; Yu Z; Tian S; Li Y; Wang Y
Lung Cancer; 2020 Aug; 146():290-296. PubMed ID: 32615523
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and adverse effets of nimotuzumab plus palitaxel liposome and carboplatin in the treatment for advanced non-small cell lung cancer].
Qi DL; Wang HQ; Li Y; Huang CB; Wang QS; Xu L; Yang YZ; Cui Y; Xin L
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):152-5. PubMed ID: 22780937
[TBL] [Abstract][Full Text] [Related]
14. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
Yan GY; Xu ZY; Deng HB; Wan ZY; Zhang L; Zhu JY
Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
[TBL] [Abstract][Full Text] [Related]
15. The Effect of PD-1 Inhibitor Combined with Chemotherapy on the Level of Peripheral Blood T Lymphocytes among Patients with Non-Small-Cell Lung Cancer and Its Relationship with Prognosis.
Zhao Y; He J; Zhou S; Ning R; Zhao W; Wang H; Su C; Jiang W; Zhong X; Yu Q
Comput Math Methods Med; 2022; 2022():1679191. PubMed ID: 36118825
[TBL] [Abstract][Full Text] [Related]
16. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC).
Cedrés S; Nuñez I; Longo M; Martinez P; Checa E; Torrejón D; Felip E
Clin Lung Cancer; 2011 May; 12(3):172-9. PubMed ID: 21663860
[TBL] [Abstract][Full Text] [Related]
17. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
Jiang AG; Chen HL; Lu HY
BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
[TBL] [Abstract][Full Text] [Related]
18. [Value of carcinoembryonic antigen levels in predicting the efficacy of EGFR-TKI in advanced non-small cell lung cancer harboring EGFR mutations].
Jin B; Zhang Y; Zhang X; Li R; Lou Y; Niu Y; Huang A; Han B
Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(30):2327-31. PubMed ID: 25399971
[TBL] [Abstract][Full Text] [Related]
19. Positive reactions for both Cyfra21-1 and CA125 indicate worst prognosis in non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Yamamoto N; Iida T
Anticancer Res; 2003; 23(3C):2869-74. PubMed ID: 12926125
[TBL] [Abstract][Full Text] [Related]
20. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.
Dal Bello MG; Filiberti RA; Alama A; Orengo AM; Mussap M; Coco S; Vanni I; Boccardo S; Rijavec E; Genova C; Biello F; Barletta G; Rossi G; Tagliamento M; Maggioni C; Grossi F
J Transl Med; 2019 Mar; 17(1):74. PubMed ID: 30849967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
